Atrial tachycardia: Mechanisms and management

Expert Review of Cardiovascular Therapy

Volumn 6, Issue 6, 2008, Pages 811-822

  Patel, Apoor ^a   Markowitz, Steven M ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Atrial flutter; Atrial tachycardia; Atypical flutter; Macroreentry

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DOFETILIDE; FLECAINIDE; HEPARIN; IBUTILIDE; LOW MOLECULAR WEIGHT HEPARIN; SOTALOL; VERAPAMIL; WARFARIN; DIAGNOSTIC AGENT; VASODILATOR AGENT;

ACTION POTENTIAL; ATRIOVENTRICULAR BLOCK; CARDIOVERSION; CATHETER ABLATION; CONGENITAL HEART DISEASE; DIRECT CURRENT; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SENSITIVITY; ELECTROCARDIOGRAPHY; FONTAN PROCEDURE; HEART ARRHYTHMIA; HEART ATRIUM CONDUCTION; HEART ATRIUM FLUTTER; HEART AUTOMATICITY; HEART ELECTROPHYSIOLOGY; HEART HEMODYNAMICS; HEART MUSCLE FIBROSIS; HEART RATE; HUMAN; HYPERTENSION; INTRACARDIAC THROMBOSIS; OUTCOME ASSESSMENT; P WAVE; PATHOPHYSIOLOGY; POPULATION RISK; QT PROLONGATION; RADIOFREQUENCY ABLATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA; TACHYCARDIA; TORSADE DES POINTES; METHODOLOGY;

ADENOSINE; ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ATRIAL FLUTTER; CATHETER ABLATION; ELECTROCARDIOGRAPHY; HUMANS; TACHYCARDIA, SUPRAVENTRICULAR; VASODILATOR AGENTS;

EID: 48249092005     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.6.6.811     Document Type: Review

References (47)

1. Saoudi N, Cosio F, Waldo A et al. Classification of atrial flutter and regular atrial tachycardia according to electrophysiologic mechanism and anatomic bases: a statement from a joint expert group from the working group of arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J. Cardiovasc. Electrophysiol. 12, 852-866 (2001).
2. Kistler PM, Roberts-Thompson KC, Haqqani HM et al. P-wave morphology in focal atrial tachycardia: development of an algorithm to predict the anatomic site of origin. J. Am. Coll. Cardiol. 48, 1010-1017 (2006).
3. Wren C. Incessant tachycardias. Eur. Heart J. Suppl. 19, E32-E59 (1998).
4. Jais P, Sanders P, Hsu LF et al. Flutter localized to the anterior left atrium after catheter ablation of atrial fibrillation. J. Cardiavasc. Electrophysiol. 3, 279-285 (2006).
5. Lerman BB, Beladinelli L. Cardiac electrophysiology of adenosine: basic and clinical concepts. Circulation 83, 1499-1509 (1991).
6. Iwai S, Markowitz SM, Stein KM et al. Response to adenosine differentiates focal from macroreentrant atrial tachycardia: validation using three-dimensional electroanatomic mapping. Circulation 106, 2793-2799 (2006).
7. Markowitz SM, Stein KM, Mittal S, Slotwiner DJ, Lerman BB. Differential effects of adenosine on focal and macroreentrant atrial tachycardia. J. Cardiovasc. Electrophysiol. 10, 489-495 (1999).
8. Markowitz SM, Nemirovsky D, Stein KM et al. Adenosine-insensitive focal atrial tachycardia. J. Am. Call. Cardiol. 49, 1324-1333 (2007).
9. Blomstrom-Lundqvist C, Scheinman MM, Aloit EM et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines writing Committee to Develop Guidelines for the Management of Patients with supraventricular Arrhythmias. J. Am. Coll. Cardiol. 42, 1493-1531 (2003).
10. Higa S, Tai CT, Lin YJ et al. Focal atrial tachycardia: new insight from noncontact mapping and catheter ablation. Circulation 109, 84-91 (2004).
11. Poty H, Saoudi N, Nair M, Anselme F, Letac B. Radiofrequency catheter ablation of atrial flutter. Further insights into the various types of isthmus block: application to ablation during sinus rhythm. Circulation 94, 3204-3213 (1996).
12. Pappone C, Stabile G, De Simone A. Role of catheter-induced mechanical trauma in localization of target sites of radiofrequency ablation in automatic atrial tachycardia. J. Am. Coll. Cardiol. 27, 1090-1097 (1996).
13. Frey B, Kreiner G, Gwechenberger M, Gössinger HD. Ablation of atrial tachycardia originating from the vicinity of the atrioventricular node: significance of mapping both sides of the interatrial septum. J. Am. Coll. Cardiol. 38, 394-400 (2001).
14. Kistler PM, Sanders P, Fynn SP et al. Electrophysiological and electrocardiographic characteristics of focal atrial tachycardia. originating from the pulmonary veins: acute and long-term outcomes of radiofrequency ablation. Circulation 108, 1968-1975 (2003).
15. Dong J, Zrenner B, Schreieck J. Catheter ablation of left atrial focal tachycardia guided by electroanatomic mapping and new insights into interatrial electrical conduction. Heart Rhythm 2, 578-591 (2005).
16. Waldo A, Feld G. Inter-relationships of atrial fibrillation and atrial flutter. J. Am. Coll. Cardiol. 51, 779-786 (2008).
17. Cheng J, Cabeen WR, Scheinman M. Right atrial flutter due to lower loop reentry. Mechanism and anatomic substrates. Circulation 99, 1700-1705 (1999).
18. Yang Y, Cheng J, Bochoeyer A et al. Atypical right atrial flutter patterns. Circulation 103, 3092-3098 (2001).
19. Stevenson WG, Sager PT, Friedman PL. Entrainment techniques for mapping atrial and ventricular tachycardias. J. Cardiovasc. Electrophysiol. 6, 201-216 (1995).
20. Kall JG, Rubenstein DS, Kopp DE et al. Atypical atrial flutter originating from the right atrial free wall. Circulation 101, 270-279 (2000).
21. Tai CT, Liu TY, Lee PC et al. Non-contact mapping to guide radiofrequency ablation of atypical right atrial flutter. J. Am. Coll. Cardiol. 44, 1080-1086 (2004).
22. Jais P, Shah DC, Haissaguerre M et al. Mapping and ablation of left atrial flutters. Circulation 101, 2928-2934 (2000)
23. Markowitz SM, Brodman RF, Stein KM et al. Lesional tachycardias related to mitral valve surgery. J. Am. Coll. Cardiol. 39, 1973-1983 (2002).
24. Gerstenfeld EP, Callans DJ, Dixit S et al. Mechanisms of organized left atrial tachycardias occurring after pulmonary vein isolation. Circulation 110, 1351-1357 (2004).
25. Ouyang F, Ernst S, Vogtmann T et al. Characterization of reentrant circuits in left atrial macroreentrant tachycardia: critical isthmus block can prevent atrial tachycardia recurrence. Circulation 105, 1934-1942 (2002).
26. Marrouche NF, Natale A, Wazni OM et al. Left septal atrial flutter. Circulation 109, 2440-2447 (2004).
27. Triedman JK. Arrhythmias in adults with congenital heart disease. Heart 87, 383-389 (2002).
28. Mesas CE, Pappone C, Lang CC et al. Left atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation: electroanatomic characterization and treatment. J. Am. Coll. Cardiol. 44, 1071-1079 (2004).
29. Pappone C, Manguso F, Vicedomini G et al. Prevention of iatrogenic atrial tachycardia after ablation of atrial. fibrillation: a prospective randomized study comparing circumferential pulmonary vein ablation with a modified approach. Circulation 110, 3036-3042 (2002).
30. Thomas SP. Nunn GR, Nicholson IA et al. Mechanism, localization and cure of atrial arrhythmias occurring after a new intraoperative endocardial radiofrequency ablation procedure for atrial fibrillation. J. Am. Coll. Cardiol. 35, 442-450 (2000).
31. Schreck DM, Rivera AR, Tricarico VJ. Emergency management of atrial fibrillation and flutter: intravenous diltiazem versus intravenous digoxin. Ann. Emerg. Med. 29, 135-140 (1997).
32. Phillips BG, Gandhi AJ, Sanoski CA, Just VL, Bauman JL. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter. Pharmacotherapy 17, 1238-1245 (1997).
33. Stambler BS, Wood MA, Ellenbogen KA. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiologic determinants of enhanced cardioversion efficacy. Circulation 96, 4298-4306 (1997).
34. Crijns HJ, VanGelder IC, Tieleman RG et al. Long-term outcome of electrical cardioversion in patients with chronic atrial flutter. Heart 77, 56-61 (1997).
35. Singh S, Zoble RG, Yellen L et al. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. Circulation 102, 2385-2390 (2000).
36. Pedersen OD, Bagger H, Keller N. Efficacy of dofetilide in the treatment of atria [fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy. Circulation 104, 292-306 (2001).
37. Elhendy A, Gentile F, Khandheria B K et al. Thromboembolic complications after electrical cardioversion in patients with atrial flutter. Am. J. Med. 111, 433-438 (2001).
38. Gallagher M, Hennessy B, Edvardsson N et al. Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion. J. Am. Coll. Cardiol. 40, 926-933 (2002).
39. Seidl K, Hauer B, Sichwick NG et al. Risk of thromboembolic events in patients with atrial flutter. Am. J. Cardiol. 82, 580-583 (1998).
40. Weiss R, Marcovitz P, Knight BP et al. Acute changes in spontaneous echo contrast and atrial function after cardioversion of persistent atrial flutter. Am. J. Cardiol. 82, 1052-1055(1998).
41. Nabar A, Rodriguez LM, Timmermans C, Smeets JL, Wellens HJ. Radiofrequency ablation of 'class IC atrial flutter' in patients with resistant atrial fibrillation. Am. J. Cardiol. 83, 785-787 (1999).
42. Schumacher B, Jung W, Lewalter T, Valithaus C, Wolpert C, Lüderitz B. Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation. Am. J. Cardiol. 83, 710-713 (1999).
43. Willems S, Weiss C, Ventura R et al. Catheter ablation of atrial flutter guided by electroanatomic mapping (CARTO): a randomized comparison to the conventional approach. J. Cardiovasc. Electrophysiol. 11, 1223-1230 (2000).
44. Kottkamp H, Hügl B, Krauss B et al. Electromagnetic versus fluoroscopic mapping of the inferior isthmus for ablation of typical atrial flutter: a prospective randomized study. Circulation 102, 2082-2096 (2000).
45. Hsieh MH, Tai CT, Chiang CE et al. Recurrent atrial flutter and atrial fibrillation after catheter ablation of the cavotricuspid isthmus: a very long-term follow-up of 333 patients. J. Interv. Card. Electrophysiol. 7, 225-231 (2002).
46. Bertaglia E, Zoppo F, Bonso A et al. Long term follow up of radiofrequency catheter ablation of atrial flutter: clinical course and predictors of atrial fibrillation occurrence. Heart 90, 59-63 (2004).
47. Chinitz JS, Gerstenfeld EP, Marchlinski FE, Callans DJ. Atrial fibrillation is common after ablation of isolated atrial flutter during long-term follow-up. Heart Rhythm 4, 1029-1033 (2007).